Case Studies

See Our Work
in Action

Tailored solutions geared towards real-world results

We’re proud of the difference we’ve made for our clients. Explore the case studies below for a sampling of our capabilities.

Filter case studies

Data Analytics

How do you measure the value of patient support programs?

View Case Study

Modeling

Demonstrating the value of a first-in-class, breakthrough technology

View Case Study

Value + Access Strategy

Pricing innovative therapies that significantly improve patient care

View Case Study

Data Analytics

Understanding patient outcomes in co-pay accumulator adjustment programs

View Case Study

Modeling

Improving the modeling of Alzheimer's disease progression

View Case Study

Value + Access Strategy

Evidence generation planning to support value demonstration and market access

View Case Study

Value + Access Strategy

Taking the pulse of industry trends and policies

View Case Study

Data Analytics

Exploring treatment patterns and outcomes using Medicare 100% data

View Case Study

Modeling

Maximizing the economic value of a novel therapy in oncology and facilitating payer engagement

View Case Study

Data Analytics

Medicare insights into patients with mCRPC

View Case Study

Modeling

Developing a dynamic hepatitis C virus (HCV) transmission model

View Case Study

Modeling

Estimating the impact of a new treatment for major depressive disorder (MDD) on availability of psychiatry resources

View Case Study

Modeling

Empirically investigating time-varying cost-effectiveness

View Case Study

Value + Access Strategy

How much funding should we set aside for our new patient support program?

View Case Study

Value + Access Strategy

How high are hospital markups for physician-administered therapies?

View Case Study

Value + Access Strategy

What are households’ non-medical costs to accommodate Duchenne muscular dystrophy?

View Case Study

Value + Access Strategy

How accurate have U.S. spending predictions been for novel therapies?

View Case Study

Data Analytics

Non-alcoholic steatohepatitis as a risk factor in hepatocellular carcinoma development

View Case Study

Modeling

FDA regulatory support via quantitative benefit-risk analysis

View Case Study

Data Analytics

Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults

View Case Study

Data Analytics

Estimating the obesity-attributable risk of cardiovascular disease (CVD)

View Case Study